Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-03-01
著者
-
Mandrioli Roberto
Faculty Of Pharmacy Department Of Pharmaceutical Sciences Alma Mater Studiorum-university Of Bologna
-
Conti Matteo
Laboratory Of Clinical Pharmacology And Toxicology Hospital "s. Maria Delle Croci
-
Raggi Maria
Pharmaco-toxicological Analysis Laboratory Department Of Pharmaceutical Sciences
-
Raggi Maria
Faculty Of Pharmacy Department Of Pharmaceutical Sciences Alma Mater Studiorum - University Of Bolog
-
MERCOLINI Laura
Faculty of Pharmacy, Department of Pharmaceutical Sciences, Alma Mater Studiorum - University of Bol
-
Leonardi Claudio
Drug Addiction Center For The Prevention And Treatment Of Drug Dependence And Alcoholism
-
Mercolini Laura
Laboratory Of Pharmaco-toxicological Analysis Department Of Pharmaceutical Sciences Faculty Of Pharm
-
Gerra Gilberto
National Department On Drug Policy
-
Mercolini Laura
Faculty Of Pharmacy Department Of Pharmaceutical Sciences Alma Mater Studiorum-university Of Bologna
関連論文
- HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma
- Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction
- Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection
- Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
- Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
- HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
- Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes